血清同型半胱氨酸水平与冠心病严重程度相关性的探讨

被引:32
作者
李秀昌
胡燕燕
张运
李继福
李华
傅善基
陈玉国
机构
[1] 山东大学齐鲁医院心内科
[2] 山东大学齐鲁医院中心实验室
[3] 山东大学齐鲁医院急症科
关键词
高半胱氨酸; 冠状动脉疾病; 色谱法,高压液相;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
目的 :探讨血清同型半胱氨酸水平与冠心病严重程度的关系。方法 :研究对象 194例 ,采用自动生化分析仪测定血脂、血糖、尿素氮、肌酐等。应用高效液相色谱法测定血清同型半胱氨酸浓度。选择性冠状动脉造影的 13 2例计算冠脉病变支数和Gensini冠脉病变积分。采用SAS软件分析。结果 :急性心肌梗死组血清同型半胱氨酸水平显著高于其它各组 ,正常对照组则明显低于冠心病组 ;而心绞痛组和陈旧性心肌梗死组差异无显著性。血清同型半胱氨酸水平与冠脉病变积分呈正相关 (r =0 .76,P <0 0 0 1) ,多元逐步回归分析剔除了其它常见影响因素后这种相关性仍然存在。结论 :血清同型半胱氨酸水平升高是冠心病的独立危险因素 ;不同类型的冠心病患者血清同型半胱氨酸水平差异有显著性 ,血清同型半胱氨酸水平升高是促使急性心肌梗死发生的可能因素 ;随着血清同型半胱氨酸水平升高 ,罹患冠心病危险性增加。
引用
收藏
页码:301 / 303
页数:3
相关论文
共 8 条
[1]  
A more meaningful scoring system for determining the severity of coronary heart disease. Gwnsins GG. The American Journal of Cardiology . 1983
[2]  
A protective study of plasma homocysteine and risk of myocardial infarction in US physicians. Stampfer MJ,Malinow MR,Willett WC,et al. The Journal of The American Medical Association . 1992
[3]  
Hyperhomocysteinemia and low pyridoxal phosphate:Common and independent reversible risk factors for coronary artery disease. Robinson K,Mayer EL,Miller DP,et al. Circulation . 1995
[4]  
Abnormally high thromboxane biorynthesis in homozygous homocystinuria:Evidence for platelet involvement and probucol sensitive mechanism. Di MG,Davi G,Margaglione M,et al. The Journal of Clinical Investigation . 1993
[5]  
Homocyteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Gallagher PM,Meleady R,Shields DC,et al. Circulation . 1996
[6]  
On the limitation of therapeutic intervention trials in ischemic heart disease: A clinician′s viewpoint. Seizer A. The American Journal of Cardiology . 1982
[7]  
Hyperhomocysteinemia-an emerging and important risk factor for thromboembolic and cardiovascular disease. Susan C,Louis M,Vivlan F. Clinical Chemistry . 1996
[8]  
Plasma homocysteine as an risk factor for vascular disease. Graham LM,Leslie ED,Helga MR,et al. The Journal of The American Medical Association . 1997